EG24141A - Method for preparing a composition - Google Patents

Method for preparing a composition

Info

Publication number
EG24141A
EG24141A EG20010680A EG20010680A EG24141A EG 24141 A EG24141 A EG 24141A EG 20010680 A EG20010680 A EG 20010680A EG 20010680 A EG20010680 A EG 20010680A EG 24141 A EG24141 A EG 24141A
Authority
EG
Egypt
Prior art keywords
preparing
composition
Prior art date
Application number
EG20010680A
Other languages
English (en)
Inventor
Busson Patrick
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8169074&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EG24141(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of EG24141A publication Critical patent/EG24141A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EG20010680A 2000-06-27 2001-06-24 Method for preparing a composition EG24141A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00113535 2000-06-27

Publications (1)

Publication Number Publication Date
EG24141A true EG24141A (en) 2008-08-06

Family

ID=8169074

Family Applications (1)

Application Number Title Priority Date Filing Date
EG20010680A EG24141A (en) 2000-06-27 2001-06-24 Method for preparing a composition

Country Status (38)

Country Link
US (3) US6534087B2 (da)
EP (1) EP1296656B1 (da)
JP (2) JP4149803B2 (da)
KR (1) KR100557845B1 (da)
CN (1) CN1236764C (da)
AR (1) AR029278A1 (da)
AT (1) ATE334662T1 (da)
AU (2) AU8184601A (da)
BR (1) BRPI0112014B1 (da)
CA (1) CA2411153C (da)
CY (1) CY1105714T1 (da)
CZ (1) CZ301813B6 (da)
DE (1) DE60121953T2 (da)
DK (1) DK1296656T3 (da)
EC (1) ECSP024401A (da)
EG (1) EG24141A (da)
ES (1) ES2269441T3 (da)
HK (1) HK1058314A1 (da)
HR (1) HRP20021009B1 (da)
HU (1) HU229550B1 (da)
IL (2) IL153282A0 (da)
JO (1) JO2247B1 (da)
MA (1) MA26922A1 (da)
ME (1) MEP90608A (da)
MX (1) MXPA02012583A (da)
MY (1) MY129798A (da)
NO (1) NO332181B1 (da)
NZ (1) NZ523024A (da)
PE (1) PE20020101A1 (da)
PL (1) PL203804B1 (da)
PT (1) PT1296656E (da)
RU (1) RU2244542C2 (da)
SI (1) SI1296656T1 (da)
TW (1) TWI278325B (da)
UY (1) UY26799A1 (da)
WO (1) WO2002000201A2 (da)
YU (1) YU96602A (da)
ZA (1) ZA200209649B (da)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9827423D0 (en) * 1998-12-11 1999-02-03 Relax Limited Method of drying a solution
MXPA02012583A (es) * 2000-06-27 2003-04-10 Hoffmann La Roche Metodo para preparacion de una composicion.
US20030027786A1 (en) 2001-06-06 2003-02-06 Karsten Maeder Lipase inhibiting composition
MY135783A (en) * 2001-09-07 2008-06-30 Meiji Dairies Corp Nutritional composition for controlling blood sugar level
RU2297221C2 (ru) * 2002-04-26 2007-04-20 Ф.Хоффманн-Ля Рош Аг Фармацевтическая композиция, включающая ингибитор липазы и глюкоманнан
KR100517072B1 (ko) * 2002-11-25 2005-09-26 주식회사 태평양 폴리올/고분자 마이크로캡슐 및 이를 이용한 효소 안정화방법
US9174176B2 (en) 2003-01-09 2015-11-03 Disperse Systems, Inc. Ultrasonic dispersion apparatus, system, and method
WO2005021056A1 (en) * 2003-08-21 2005-03-10 Cns, Inc. Effervescent delivery system
US8030362B2 (en) * 2003-12-12 2011-10-04 Otic Pharma Ltd. Compositions for treatment of ear disorders and methods of use thereof
US8940321B2 (en) 2003-12-12 2015-01-27 Otic Pharma Ltd. Compositions for treatment of ear disorders and methods of use thereof
CA2562213A1 (en) * 2004-04-06 2005-11-24 Rpg Life Sciences Limited Mouth dissolvable and meltable, and water dispersable delivery formulation
CA2579500A1 (en) * 2004-09-15 2006-03-23 Banyu Pharmaceutical Co., Ltd. Sampling method and sampling device, and logd measuring method and logd measuring system
EP2163196A3 (en) * 2004-12-31 2010-11-03 Mikhail Yurievich Gotovsky Device for measuring the presence of foreign substances in a living organism and for individually selecting preparations for increasing an organism's life activity
US20060198856A1 (en) * 2005-03-01 2006-09-07 Keith Whitehead Ibuprofen suspension stabilized with docusate sodium
WO2006110809A2 (en) * 2005-04-12 2006-10-19 Elan Pharma International, Limited Nanoparticulate lipase inhibitor formulations
US7984717B2 (en) * 2005-04-29 2011-07-26 Medtronic, Inc. Devices for augmentation of lumen walls
US20070060610A1 (en) * 2005-06-16 2007-03-15 Wempe Michael F Methods and pharmaceutical formulations for increasing bioavailability
WO2006136197A1 (en) 2005-06-21 2006-12-28 V. Mane Fils Smoking device incorporating a breakable capsule, breakable capsule and process for manufacturing said capsule
US20070048364A1 (en) * 2005-08-04 2007-03-01 Yingxu Peng Free flowing granules containing carbomer
KR100669497B1 (ko) * 2005-08-17 2007-01-16 보람제약주식회사 안정성과 용출률이 뛰어난 약리학적 조성물 및 그 제조방법
AR056499A1 (es) * 2005-09-06 2007-10-10 Serapis Farmaceuticals Ltd Compuestos
EP1951186A4 (en) 2005-10-19 2009-11-04 Menni Menashe Zinger METHODS FOR TREATING HYPERHIDROSIS
DK1973406T3 (da) 2005-12-28 2014-06-23 Advanced Bionutrition Corp Fremføringsmiddel til probiotiske bakerier omfattende en tør blanding af polysaccharider, saccharider, polyoler i glasform
US8968721B2 (en) 2005-12-28 2015-03-03 Advanced Bionutrition Corporation Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
FR2895908B1 (fr) * 2006-01-12 2008-03-28 France Etat Procede de fabrication d'une forme pharmaceutique de phosphate d'oseltamivir
BRPI0708108B1 (pt) 2006-02-20 2021-12-14 Chugai Seiyaku Kabushiki Kaisha Composição farmacêutica compreendendo fosfato de oseltamivir
US7903256B2 (en) 2006-03-16 2011-03-08 Duke University Methods, systems, and computer program products for performing real-time quadrature projection based Fourier domain optical coherence tomography
CN1820744B (zh) * 2006-04-04 2011-01-26 中国人民解放军军事医学科学院毒物药物研究所 磷酸奥司他韦颗粒剂及其制备方法
EP1872777A1 (en) * 2006-06-27 2008-01-02 LEK Pharmaceuticals D.D. Pharmaceutical composition comprising tetrahydrolipstatin
KR100812824B1 (ko) 2006-09-27 2008-03-12 주식회사 제닉 키토산과 폴리에틸렌글리콜을 이용한 생체친화성 저독성필름
CA2673120C (en) 2006-12-18 2012-08-07 Advanced Bionutrition Corporation A dry food product containing live probiotic
CA2686286A1 (en) * 2007-05-18 2008-11-27 Tti Ellebeau, Inc. Transdermal delivery devices assuring an improved release of an active principle through a biological interface
KR101439470B1 (ko) * 2007-05-22 2014-09-16 한미사이언스 주식회사 오를리스타트 및 대변 연화제를 포함하는 비만의 예방 또는치료용 조성물
US20100317642A1 (en) * 2007-10-15 2010-12-16 Inventis Dds Pvt Limited Pharmaceutical composition of orlistat
PL216542B1 (pl) 2008-03-20 2014-04-30 Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna Sposób wytwarzania stabilnej kompozycji orlistatu w postaci kapsułkowanego proszku
GB0900551D0 (en) * 2009-01-14 2009-02-11 Horton Richard Ingestible compositions and processes of preparation
CA2756883C (en) 2009-03-27 2018-01-09 Advanced Bionutrition Corp. Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
CA2763074C (en) 2009-05-26 2021-02-23 Moti Harel Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making
EP2482802A4 (en) * 2009-09-29 2013-08-07 Michael Burnet NEW PESTICIDE FORMULATIONS
KR100940745B1 (ko) * 2009-10-15 2010-02-04 광동제약 주식회사 오를리스타트 및 아타풀지트 함유 복합제의 코팅펠렛 및 이를 이용한 제제
NZ601017A (en) 2010-01-28 2014-07-25 Advanced Bionutrition Corp Dry glassy composition comprising a bioactive material
US9504750B2 (en) 2010-01-28 2016-11-29 Advanced Bionutrition Corporation Stabilizing composition for biological materials
KR101021030B1 (ko) * 2010-03-25 2011-03-09 엘지이노텍 주식회사 형광체 코팅방법, 발광장치 제조방법 및 코팅된 형광체
RU2579972C2 (ru) * 2010-04-07 2016-04-10 Мицубиси Гэс Кемикал Компани, Инк. Стабильная при хранении содержащая s-аденозил-l-метионин композиция высушенных дрожжей и способ ее производства
CN103140145B (zh) 2010-08-13 2014-08-20 高级生物营养公司 用于生物材料的干的贮存稳定用组合物
WO2012058668A2 (en) 2010-10-29 2012-05-03 Western University Of Health Sciences Ternary mixture formulations
PL2680815T3 (pl) 2011-03-01 2017-02-28 The Procter & Gamble Company Porowate, ulegające rozpadowi stałe podłoże do zastosowań związanych z higieną osobistą
CA2866889C (en) 2012-03-23 2021-08-31 Advanced Bionutrition Corporation Stabilizing composition for biological materials
CN103222964B (zh) * 2013-01-29 2014-10-08 青岛大学 一种奥利司他口服制剂及其制备方法
GB2524496A (en) * 2014-03-24 2015-09-30 British Airways Plc Dynamic tracking and control of passenger travel progress
WO2016210251A1 (en) 2015-06-25 2016-12-29 Ascus Biosciences, Inc. Methods, apparatuses, and systems for analyzing microorganism strains from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
US10851399B2 (en) 2015-06-25 2020-12-01 Native Microbials, Inc. Methods, apparatuses, and systems for microorganism strain analysis of complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
US9938558B2 (en) 2015-06-25 2018-04-10 Ascus Biosciences, Inc. Methods, apparatuses, and systems for analyzing microorganism strains from complex heterogeneous communities, predicting and identifying functional relationships and interactions thereof, and selecting and synthesizing microbial ensembles based thereon
PL3328215T3 (pl) 2015-07-29 2021-12-13 Advanced Bionutrition Corp. Stabilne suche kompozycje probiotyczne do specjalnych zastosowań dietetycznych
JP6778051B2 (ja) * 2016-08-18 2020-10-28 沢井製薬株式会社 オセルタミビルリン酸塩含有医薬組成物
US12018313B2 (en) 2016-12-28 2024-06-25 Native Microbials, Inc. Methods, apparatuses, and systems for microorganism strain analysis of complex heterogeneous communities with tracer analytics, determination of functional relationships and interactions thereof, and synthesis of microbial ensembles
EP3562954A1 (en) 2016-12-28 2019-11-06 Ascus Biosciences, Inc. Methods, apparatuses, and systems for analyzing complete microorganism strains in complex heterogeneous communities, determining functional relationships and interactions thereof, and identifying and synthesizing bioreactive modificators based thereon
WO2019069108A1 (en) * 2017-10-04 2019-04-11 Debreceni Egyetem SOLID GALENIC FORM, MOLDED, GASTRIC RETENTION AND EXTENDED RELEASE AND METHOD OF PREPARING THE SAME

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS608117B2 (ja) * 1977-02-08 1985-02-28 財団法人微生物化学研究会 新生理活性物質エステラスチンおよびその製造法
US4489438A (en) * 1982-02-01 1984-12-18 National Data Corporation Audio response system
CA1247547A (en) 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
JP3069458B2 (ja) 1992-01-29 2000-07-24 武田薬品工業株式会社 口腔内崩壊型錠剤およびその製造法
US5560921A (en) 1992-06-01 1996-10-01 The Procter & Gamble Company Chewable decongestant compositions
US5343672A (en) 1992-12-01 1994-09-06 Scherer Ltd R P Method for manufacturing freeze dried dosages in a multilaminate blister pack
JP3722294B2 (ja) * 1993-02-23 2005-11-30 ワーナー−ランバート・コンパニー 実質的にアルコールを含有しない医薬組成物の製造方法
DE4317320A1 (de) 1993-05-25 1994-12-01 Boehringer Mannheim Gmbh Neue Thiazolidindione und diese enthaltende Arzneimittel
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5536264A (en) * 1993-10-22 1996-07-16 The Procter & Gamble Company Absorbent composites comprising a porous macrostructure of absorbent gelling particles and a substrate
US5523106A (en) * 1994-02-03 1996-06-04 Nabisco, Inc. Juice-based expanded snacks and process for preparing them
SG45864A1 (en) 1995-02-27 1999-04-27 Novel selective inhibitors of viral or bacterial neuraminidases
DK0976734T3 (da) 1995-02-27 2005-12-27 Gilead Sciences Inc Selektive inhibitorer af viral eller bakteriel neuraminidase
BR9609188A (pt) * 1995-06-07 1999-05-11 Quadrant Holdings Cambridge Métodos para incorporar substâncias de modo estável dentro de matrizes de vidro espumado secas e composições obtidas desse modo
US5763483A (en) 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
DK0893992T3 (da) * 1996-04-16 2004-06-01 Novartis Consumer Health Sa Hurtigt sönderdelende oral doseringsform
US5766520A (en) * 1996-07-15 1998-06-16 Universal Preservation Technologies, Inc. Preservation by foam formation
JP2001505190A (ja) * 1996-10-14 2001-04-17 エフ・ホフマン―ラ ロシュ アーゲー 微粉状調製物の調製方法
US6004996A (en) 1997-02-05 1999-12-21 Hoffman-La Roche Inc. Tetrahydrolipstatin containing compositions
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
JPH11137208A (ja) 1997-11-14 1999-05-25 Nikken Chem Co Ltd 口腔内速溶性固形物及びその製造方法
US6267952B1 (en) 1998-01-09 2001-07-31 Geltex Pharmaceuticals, Inc. Lipase inhibiting polymers
CN1148169C (zh) * 1998-04-09 2004-05-05 弗·哈夫曼-拉罗切有限公司 通过溶于压缩气体和表面活性剂制备(亚)微米级粒子的方法
PT1105122E (pt) 1998-08-14 2005-08-31 Hoffmann La Roche Composicoes farmaceuticas que contem inibidores de lipase
BR9912979B1 (pt) 1998-08-14 2010-09-21 composição farmacêutica administrável oralmente, tablete de mascar, cápsula e uso de chitosan.
GB9827423D0 (en) * 1998-12-11 1999-02-03 Relax Limited Method of drying a solution
US6342249B1 (en) * 1998-12-23 2002-01-29 Alza Corporation Controlled release liquid active agent formulation dosage forms
GB9900416D0 (en) 1999-01-08 1999-02-24 Alizyme Therapeutics Ltd Inhibitors
ES2307482T3 (es) 1999-02-10 2008-12-01 Pfizer Products Inc. Dispersiones farmaceuticas solidas.
GB9904629D0 (en) * 1999-03-02 1999-04-21 Danbiosyst Uk Oral drug delivery system
FR2791569B1 (fr) * 1999-03-31 2003-05-09 Pf Medicament Composition ou structure microporeuse expansee isotrope a dissolution rapide a usage pharmaceutique, veterinaire, dietetique, alimentaire ou cosmetique et son procede d'obtention
MXPA02012583A (es) * 2000-06-27 2003-04-10 Hoffmann La Roche Metodo para preparacion de una composicion.

Also Published As

Publication number Publication date
ME00672B (me) 2011-12-20
YU96602A (sh) 2005-03-15
IL153282A0 (en) 2003-07-06
KR100557845B1 (ko) 2006-03-10
MA26922A1 (fr) 2004-12-20
PE20020101A1 (es) 2002-02-12
EP1296656A2 (en) 2003-04-02
PL203804B1 (pl) 2009-11-30
HRP20021009A2 (en) 2004-02-29
CZ2003212A3 (cs) 2003-06-18
ZA200209649B (en) 2004-03-10
CA2411153A1 (en) 2002-01-03
AU8184601A (en) 2002-01-08
CA2411153C (en) 2007-01-30
HUP0302060A2 (hu) 2003-09-29
ECSP024401A (es) 2003-02-06
PL365803A1 (en) 2005-01-10
EP1296656B1 (en) 2006-08-02
US7074431B2 (en) 2006-07-11
DK1296656T3 (da) 2006-11-27
WO2002000201A3 (en) 2002-04-18
JP2004501184A (ja) 2004-01-15
HUP0302060A3 (en) 2006-07-28
UY26799A1 (es) 2001-12-28
BRPI0112014B1 (pt) 2016-09-13
KR20030023880A (ko) 2003-03-20
SI1296656T1 (sl) 2006-12-31
MEP90608A (en) 2011-12-20
NZ523024A (en) 2004-08-27
HU229550B1 (en) 2014-01-28
ES2269441T3 (es) 2007-04-01
ATE334662T1 (de) 2006-08-15
HRP20021009B1 (en) 2011-07-31
NO20026197D0 (no) 2002-12-23
BR0112014A (pt) 2003-05-13
NO20026197L (no) 2002-12-23
IL153282A (en) 2008-03-20
JP2007302683A (ja) 2007-11-22
AU2001281846B2 (en) 2006-04-27
US20060134205A1 (en) 2006-06-22
TWI278325B (en) 2007-04-11
NO332181B1 (no) 2012-07-16
MY129798A (en) 2007-04-30
US20020018812A1 (en) 2002-02-14
CN1236764C (zh) 2006-01-18
AR029278A1 (es) 2003-06-18
JO2247B1 (en) 2004-10-07
CN1438880A (zh) 2003-08-27
MXPA02012583A (es) 2003-04-10
US20030039614A1 (en) 2003-02-27
CY1105714T1 (el) 2010-12-22
JP4149803B2 (ja) 2008-09-17
CZ301813B6 (cs) 2010-06-30
HK1058314A1 (en) 2004-05-14
US6534087B2 (en) 2003-03-18
WO2002000201A2 (en) 2002-01-03
PT1296656E (pt) 2006-12-29
DE60121953T2 (de) 2007-03-08
RU2244542C2 (ru) 2005-01-20
DE60121953D1 (de) 2006-09-14

Similar Documents

Publication Publication Date Title
EG24141A (en) Method for preparing a composition
EG23914A (en) Process for preparing an antichnolinergic
HK1044538A1 (en) Method for preparation citalopram
HUP0303365A3 (en) Method for making polyamides
AU2001241595A1 (en) Method for preparing a contact mass
HUP0203734A3 (en) A method for preparing lysophosphatidylethanolamine
HUP0300160A3 (en) Process for preparing (+)-cis-sertraline
PL361146A1 (en) Method for producing isocyanato-organosilanes
IL144176A0 (en) Method for preparing a benzylic-type ether
HUP0104405A3 (en) Process for preparing imidachlopid
HUP0102967A3 (en) Method for producing organosilylalkyl-polysulphanes
HUP0300114A3 (en) Process for preparing flavonoid-derivatives
HUP0301649A3 (en) Process for preparing azacycloalkanoylaminothiazoles
EP1245548A4 (en) PROCESS FOR THE MANUFACTURE OF VITROCERAMIC
IL150043A0 (en) Method for preparing bromodifluoroacetic compounds
HK1047735A1 (en) Method for decorating molding
AU4663601A (en) Method for preparing 9-deoxo-8a-aza-(8a-alkyl)-8a-homoerythromycin derivativesfrom 9-deoxo-9(z)-hydroxyiminoerythromycin
IL154825A0 (en) A METHOD FOR PRODUCING Delta1-PYRROLINES
HUP0302821A2 (hu) Eljárás szubsztituált 5-amino-N-fenil-1,2,4-triazol-3-szulfonamid-származékok előállítására
AU7265900A (en) Method for producing otoplastics
HUP0500959A2 (en) Method for preparing latex
GB0004365D0 (en) Preparation method for oxazoline compounds
SG99292A1 (en) A method for producing oxide compounds
AU1079002A (en) Method for making micromolds
AU2002218768A1 (en) Method for preparing (+)-biotine